Bevacizumab for treating Hereditary Hemorrhagic Telangiectasia patients with severe hepatic involvement or refractory anemia

Mo1191 - Bevacizumab as Treatment of Bleeding in Patients with Hereditary Haemorrhagic Telangiectasia (HHT)

(2018) Jens Kjeldsen et al.   GASTROENTEROLOGY

Hereditary haemorrhagic telangiectasia: to transplant or not to transplant - is there a right time for liver transplantation?

(2016) Yannick D. Muller et al.   LIVER INTERNATIONAL

Hereditary hemorrhagic telangiectasia: to transplant or not to transplant?

(2016) Sophie Dupuis-Girod et al.   LIVER INTERNATIONAL

Bevacizumab to Treat Cholangiopathy in Hereditary Hemorrhagic Telangiectasia

(2015) Quentin Maestraggi et al.   MEDICINE

Propranolol as antiangiogenic candidate for the therapy of hereditary haemorrhagic telangiectasia

(2012) Virginia Albiñana et al.   THROMBOSIS AND HAEMOSTASIS

Natural History and Outcome of Hepatic Vascular Malformations in a Large Cohort of Patients with Hereditary Hemorrhagic Teleangiectasia

(2011) Elisabetta Buscarini et al.   DIGESTIVE DISEASES AND SCIENCES

Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells

(2010) Virginia Albiñana et al.   THROMBOSIS AND HAEMOSTASIS

International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia

(2009) M. E. Faughnan et al.   JOURNAL OF MEDICAL GENETICS

Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: In search of predictors of significant disease

(2008) Guadalupe Garcia-Tsao et al.   HEPATOLOGY